John J. Wiesehan Enters into Separation and General Release with the cbdMD, Inc. and Resigns as Chief Revenue Officer and All Other Capacities
December 03, 2021 at 05:11 pm EST
Share
On December 1, 2021, John J. Wiesehan entered into a Separation and General Release (the ‘Separation Agreement’) with the cbdMD, Inc. (the ‘Company’) and its subsidiaries resigning as Chief Revenue Officer and all other capacities, effective December 1, 2021. His resignation on December 1, 2021 was pursuant to Section 6(c) of his Employment Agreement dated July 22, 2021 (the ‘Wiesehan Employment Agreement’). Mr. Wiesehan’s responsibilities have been assumed by current Company executive management and other personnel.
cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.
CBDMD, INC. 
